LSBio
WNT11 Antibody (aa1-310)

Sample (30 ug whole cell lysate). A: Hep G2 . 10% SDS PAGE. WNT11 antibody diluted at 1:1000

WNT11 Antibody (aa1-310)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Immunocytochemistry, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse
Format:Liquid
See all Human WNT11 antibodies →
$459.00each
Catalog Number: LS-C185754-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
WNT11 antibody LS-C185754 is an unconjugated rabbit polyclonal antibody to WNT11 (aa1-310) from human. It is reactive with human and mouse. Validated for ICC, IHC and WB. Cited in 2 publications.
Application
ICC, IHC, IHC-P, WB
Reactivity
Hu, Ms
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
HWNT11 | WNT11 | Protein Wnt-11
Recommended Dilution: IF/ICC
1:100 - 1:1000
Recommended Dilution: IHC-P
1:100 - 1:1000
Recommended Dilution: WB
1:500 - 1:3000
UniProt Number
O96014
SwissProt
O96014

Target

Target
Human WNT11
Antigen Species
Human
Epitope
Human WNT11
Gene Name
WNT11

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Recombinant protein encompassing a sequence within the center region of human WNT11. The exact sequence is proprietary.
Immunogen Type
Recombinant Immunogen

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
1X PBS, pH 7, 0.025% ProClin™ 300, 20% Glycerol
Concentration
1.56 mg/mL
Volume
100 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short term storage (1-2 weeks), store at 4°C. For long term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Recommended Storage Buffer
1X PBS

WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer. Anna Kotrbová, Petra Ovesná, Tomáš Gybel', Tomasz Radaszkiewicz, Markéta Bednaríková, Jitka Hausnerová, Eva Jandáková, Luboš Minár, Igor Crha, Vít Weinberger, Ludek Záveský, Vítezslav Bryja, Vendula Pospíchalová. Theranostics. 2020 Jan;10:537-552.

PubMed: 31903136 · PMC: PMC6929979


RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy. Tomasz Radaszkiewicz, Michaela Nosková, Kristína Gömöryová, Olga Vondálová Blanárová, Katarzyna Anna Radaszkiewicz, Markéta Picková, Ráchel Víchová, Tomáš Gybel, Karol Kaiser, Lucia Demková, Lucia Kucerová, Tomáš Bárta, David Potešil, Zbynek Zdráhal, Karel Soucek, Vítezslav Bryja. eLife. 2021 October;10:e65759.

PubMed: 34702444 · PMC: PMC8550759

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.